A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease - Publications

Publications

Home »
Publications

A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease

Reference: Seminars in Arthritis and Rheumatism (2019) 49: 411-419

Link to article

Published By

Low A.H.L., Teng G.G., Pettersson S., de Sessions P.F., Ho E.X.P., Fan Q., Chu C.W., Law A.H.N., Santosa A., Lim A.Y.N., Wang Y.T., Haaland B., Thumboo J.

Back to all Publications

You may be interested in:

Transposon mutagenesis in Streptococcus species

Capsid integrity qPCR—An azo-dye based and culture-independent approach to estimate adenovirus infectivity after disinfection and in the aquatic environment

Global science meets ethnic diversity: Ian McGonigle interviews GenomeAsia100k Scientific Chairman Stephan Schuster

PhD Programme

SCELSE offers a research environment focusing on scientific excellence, recognising world-class research as the platform for future innovation, research and development.

learn more

Scholarships

As part of the talent grooming to support this fast-rising industry, the National Research Foundation (NRF), through the EWI, is providing PhD scholarships to develop research experts in Environmental and Water Technologies (EWT).

LEARN MORE

Other Programmes

view more programmes

Take a guided tour in SCELSE

Learn about our people & their expertise

Collaborate on a Research Project

Funded By: